UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The effect of tamoxifen and cisplatin on the disease-free and overall survival of patients with high risk malignant melanoma

British journal of cancer, 2000-07, Vol.83 (1), p.16-21

2000

Volltextzugriff (PDF)

Tamoxifen: is it useful in the treatment of patients with metastatic melanoma?

Journal of clinical oncology, 1994-03, Vol.12 (3), p.617-626

1994

Volltextzugriff (PDF)

A Comparison of Intravenous versus Intraperitoneal Chemotherapy for the Initial Treatment of Ovarian Cancer

Gynecologic oncology, 1994-09, Vol.54 (3), p.338-344

1994

Volltextzugriff (PDF)

A Phase I and pharmacokinetic study of high dose tamoxifen and weekly cisplatin in patients with metastatic melanoma

Cancer, 1997-03, Vol.79 (5), p.1037-1043

1997

Volltextzugriff (PDF)

Characterization of a sustained-release delivery system for combined cytokine/peptide vaccination using a poly-N-acetyl glucosamine-based polymer matrix

Clinical cancer research, 1997-06, Vol.3 (6), p.867-873

1997

Volltextzugriff (PDF)

A phase II/pharmacokinetic trial of high-dose progesterone in combination with paclitaxel

Cancer chemotherapy and pharmacology, 1999, Vol.44 (3), p.259-265

1999

Volltextzugriff (PDF)

Modulation of cisplatin resistance in human malignant melanoma cells

Cancer research (Chicago, Ill.), 1992-12, Vol.52 (24), p.6790-6796

1992

Volltextzugriff (PDF)

Clinical evaluation of intraperitoneal Pseudomonas exotoxin immunoconjugate OVB3-PE in patients with ovarian cancer

Journal of clinical oncology, 1991-12, Vol.9 (12), p.2095-2103

1991

Volltextzugriff (PDF)

The importance of tamoxifen to a cisplatin‐containing regimen in the treatment of metastatic melanoma

Cancer, 1989-04, Vol.63 (7), p.1292-1295

1989

Volltextzugriff (PDF)

Synergy between tamoxifen and cisplatin in human melanoma cells is dependent on the presence of antiestrogen-binding sites

Cancer research (Chicago, Ill.), 1997-07, Vol.57 (13), p.2657-2660

1997

Volltextzugriff (PDF)

Phase I/pharmacokinetic study of high-dose progesterone and doxorubicin

Journal of clinical oncology, 1993-12, Vol.11 (12), p.2417-2426

1993

Volltextzugriff (PDF)

Melanoma thickness and histology predict sentinel lymph node status

The American journal of surgery, 2001, Vol.181 (1), p.8-11

2001

Volltextzugriff (PDF)

Tamoxifen delays the development of resistance to cisplatin in human melanoma and ovarian cancer cell lines

British journal of cancer, 1994-09, Vol.70 (3), p.449-452

1994

Volltextzugriff (PDF)

Characterization of a human melanoma cell line with non-oestrogen receptor dependent tamoxifen resistance

Melanoma research, 1999-12, Vol.9 (6), p.531

1999

Volltextzugriff (PDF)

A phase II trial of intraperitoneal high-dose carboplatin and etoposide with granulocyte macrophage-colony stimulating factor support in patients with ovarian carcinoma

American journal of clinical oncology, 1995-02, Vol.18 (1), p.23-26

1995

Volltextzugriff (PDF)

Tamoxifen modulation of cisplatin cytotoxicity in human malignancies

International journal of cancer, 1993-12, Vol.55 (6), p.1018-1022

1993

Volltextzugriff (PDF)

Determinants of tamoxifen sensitivity control the nature of the synergistic interaction between tamoxifen and cisplatin

Cancer research (Chicago, Ill.), 1996-09, Vol.56 (17), p.3993-3997

1996

Volltextzugriff (PDF)

Increase in tumor GADD153 mRNA level following treatment correlates with response to paclitaxel

Cancer chemotherapy and pharmacology, 2000, Vol.45 (5), p.381-388

2000

Volltextzugriff (PDF)

Effective combination chemo/hormonal therapy for malignant melanoma: Experience with three consecutive trials

International journal of cancer, 1992-02, Vol.50 (4), p.553-556

1992

Volltextzugriff (PDF)

A phase I and pharmacokinetic study of intraperitoneal carboplatin and etoposide

British journal of cancer, 1993-10, Vol.68 (4), p.783-788

1993

Volltextzugriff (PDF)

Phase I and Pharmacokinetic Trial of Intraperitoneal Etoposide in Combination With the Multidrug-Resistance-Modulating Agent Dipyridamole

JNCI : Journal of the National Cancer Institute, 1991-05, Vol.83 (9), p.621-626

1991

Volltextzugriff (PDF)

The Dartmouth Regimen: Gone or Going Strong?

Cancer investigation, 1998, Vol.16 (6), p.421-423

1998

Volltextzugriff (PDF)

A phase I trial of intraperitoneal carboplatin and etoposide with granulocyte macrophage colony stimulating factor support in patients with intraabdominal malignancies

Cancer, 1994-07, Vol.74 (2), p.664-669

1994

Volltextzugriff (PDF)

A phase II study of high dose tamoxifen and weekly cisplatin in patients with metastatic melanoma

Melanoma research, 2001-06, Vol.11 (3), p.309-313

2001

Volltextzugriff (PDF)

Phase II trial of dendritic cells loaded with antigens from self-renewing, proliferating autologous tumor cells as patient-specific antitumor vaccines in patients with metastatic melanoma: final report

Cancer biotherapy & radiopharmaceuticals, 2009-06, Vol.24 (3), p.311-319

2009

Volltextzugriff (PDF)

1 – 25 von 134

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(125)
Mit Volltextzugriff
(100)

Publikationsform

Artikel
(132)
magazinearticle
(2)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(96)
Life Sciences & Biomedicine
(90)
Humans
(87)
Female
(53)
Biological And Medical Sciences
(47)
Medical Sciences
(47)
Oncology
(44)
Male
(43)
Pharmacology. Drug Treatments
(36)
Middle Aged
(29)
Antineoplastic Agents
(28)
Adult
(27)
Medicin Och Hälsovetenskap
(21)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(20)
Chemotherapy
(20)
Aged
(19)
Cisplatin - Administration & Dosage
(17)
Melanoma - Drug Therapy
(17)
Treatment Outcome
(16)
Tamoxifen - Administration & Dosage
(13)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The effect of tamoxifen and cisplatin on the disease-free and overall survival of patients with high risk malignant melanoma

Tamoxifen: is it useful in the treatment of patients with metastatic melanoma?

A Comparison of Intravenous versus Intraperitoneal Chemotherapy for the Initial Treatment of Ovarian Cancer

A Phase I and pharmacokinetic study of high dose tamoxifen and weekly cisplatin in patients with metastatic melanoma

Characterization of a sustained-release delivery system for combined cytokine/peptide vaccination using a poly-N-acetyl glucosamine-based polymer matrix

A phase II/pharmacokinetic trial of high-dose progesterone in combination with paclitaxel

Modulation of cisplatin resistance in human malignant melanoma cells

Clinical evaluation of intraperitoneal Pseudomonas exotoxin immunoconjugate OVB3-PE in patients with ovarian cancer

The importance of tamoxifen to a cisplatin‐containing regimen in the treatment of metastatic melanoma

Synergy between tamoxifen and cisplatin in human melanoma cells is dependent on the presence of antiestrogen-binding sites

Phase I/pharmacokinetic study of high-dose progesterone and doxorubicin

Melanoma thickness and histology predict sentinel lymph node status

Tamoxifen delays the development of resistance to cisplatin in human melanoma and ovarian cancer cell lines

Characterization of a human melanoma cell line with non-oestrogen receptor dependent tamoxifen resistance

A phase II trial of intraperitoneal high-dose carboplatin and etoposide with granulocyte macrophage-colony stimulating factor support in patients with ovarian carcinoma

Tamoxifen modulation of cisplatin cytotoxicity in human malignancies

Determinants of tamoxifen sensitivity control the nature of the synergistic interaction between tamoxifen and cisplatin

Increase in tumor GADD153 mRNA level following treatment correlates with response to paclitaxel

Effective combination chemo/hormonal therapy for malignant melanoma: Experience with three consecutive trials

A phase I and pharmacokinetic study of intraperitoneal carboplatin and etoposide

Phase I and Pharmacokinetic Trial of Intraperitoneal Etoposide in Combination With the Multidrug-Resistance-Modulating Agent Dipyridamole

The Dartmouth Regimen: Gone or Going Strong?

A phase I trial of intraperitoneal carboplatin and etoposide with granulocyte macrophage colony stimulating factor support in patients with intraabdominal malignancies

A phase II study of high dose tamoxifen and weekly cisplatin in patients with metastatic melanoma

Phase II trial of dendritic cells loaded with antigens from self-renewing, proliferating autologous tumor cells as patient-specific antitumor vaccines in patients with metastatic melanoma: final report

Suchergebnisse filtern